Inventor · disambiguated record
Gila Arad
Also filed as: ARAD GILA
8 granted patents·1 pending application·26 citations·filing 1998–2018
82Inventor score
Files withYISSUM RES DEV CO4YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD3ATOX BIO LTD1KAEMPFER RAYMOND1
Top patents by PatentIndex Score
9 records- 0185US9546207B2Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereofYISSUM RES DEV CO·Filed 2013·Granted Jan 17, 2017·5 cites·3 claims
- 0279US9963497B2Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2014·Granted May 8, 2018·4 cites·22 claims
- 0377US8535672B2Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereofKAEMPFER RAYMOND·Filed 2004·Granted Sep 17, 2013·8 cites·21 claims
- 0475US7060277B2Broad spectrum antagonists and vaccines directed against pyrogenic exotoxinsYISSUM RES DEV CO·Filed 2002·Granted Jun 13, 2006·5 cites·12 claims
- 0572US10280209B2Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted May 7, 2019·1 cites·17 claims
- 0660US2006222650A1Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxinsYISSUM RES DEV CO·Filed 2006·Application pending·0 cites
- 0753US11304989B2Peptides for use in the treatment of viral infectionsYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted Apr 19, 2022·0 cites·8 claims
- 0837US7189398B2Broad spectrum pyrogenic exotoxins antagonists and vaccinesYISSUM RES DEV CO·Filed 1998·Granted Mar 13, 2007·3 cites·48 claims
- 0930US9567367B2Synthetic peptides for treatment of bacterial infectionsATOX BIO LTD·Filed 2013·Granted Feb 14, 2017·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Gila Arad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →